Cargando…
Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors
Immune-checkpoint inhibitors show promising effects in the treatment of multiple tumor types. Biomarkers are biological indicators used to select patients for a systemic anticancer treatment, but there are only a few clinically useful biomarkers such as PD-L1 expression and tumor mutational burden,...
Autores principales: | Kovács, Szonja Anna, Fekete, János Tibor, Győrffy, Balázs |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462766/ https://www.ncbi.nlm.nih.gov/pubmed/37055532 http://dx.doi.org/10.1038/s41401-023-01079-6 |
Ejemplares similares
-
New Transcriptomic Biomarkers of 5-Fluorouracil Resistance
por: Fekete, János Tibor, et al.
Publicado: (2023) -
Transcriptomic datasets of cancer patients treated with immune-checkpoint inhibitors: a systematic review
por: Kovács, Szonja Anna, et al.
Publicado: (2022) -
A unified platform enabling biomarker ranking and validation for 1562 drugs using transcriptomic data of 1250 cancer cell lines
por: Tibor Fekete, János, et al.
Publicado: (2022) -
Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies
por: Menyhárt, Otília, et al.
Publicado: (2021) -
Identification of a Tumor Cell Associated Type I IFN Resistance Gene Expression Signature of Human Melanoma, the Components of Which Have a Predictive Potential for Immunotherapy
por: Ladányi, Andrea, et al.
Publicado: (2022)